0001410442-23-000004.txt : 20230615
0001410442-23-000004.hdr.sgml : 20230615
20230615102258
ACCESSION NUMBER: 0001410442-23-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230614
FILED AS OF DATE: 20230615
DATE AS OF CHANGE: 20230615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jain Vivek
CENTRAL INDEX KEY: 0001410442
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34634
FILM NUMBER: 231016237
MAIL ADDRESS:
STREET 1: ICU MEDICAL, INC.
STREET 2: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICU MEDICAL INC/DE
CENTRAL INDEX KEY: 0000883984
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330022692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
BUSINESS PHONE: 949-366-2183
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0407
4
2023-06-14
0
0000883984
ICU MEDICAL INC/DE
ICUI
0001410442
Jain Vivek
951 CALLE AMANECER
SAN CLEMENTE
CA
92673
1
1
0
0
Chairman and CEO
1
Common Stock
2023-06-14
4
M
0
6712
58.79
A
30389
D
Common Stock
2023-06-14
4
S
0
6712
185.7305
D
23677
D
Common Stock
2023-06-14
4
M
0
3637
58.79
A
27314
D
Common Stock
2023-06-14
4
S
0
3637
186.5029
D
23677
D
Common Stock
2023-06-14
4
M
0
2781
58.79
A
26458
D
Common Stock
2023-06-14
4
S
0
2781
187.434
D
23677
D
Common Stock
2023-06-14
4
M
0
8163
58.79
A
31840
D
Common Stock
2023-06-14
4
S
0
8163
188.5155
D
23677
D
Common Stock
2023-06-14
4
M
0
785
58.79
A
24462
D
Common Stock
2023-06-14
4
S
0
785
189.3167
D
23677
D
Common Stock
2023-06-14
4
M
0
1699
58.79
A
25376
D
Common Stock
2023-06-14
4
S
0
1699
190.482
D
23677
D
Common Stock
2023-06-14
4
M
0
1601
58.79
A
25278
D
Common Stock
2023-06-14
4
S
0
1601
192.0613
D
23677
D
Common Stock
2023-06-14
4
M
0
2104
58.79
A
25781
D
Common Stock
2023-06-14
4
M
0
2418
58.79
A
28199
D
Common Stock
2023-06-14
4
S
0
2418
194.0219
D
25781
D
Common Stock
2023-06-14
4
M
0
100
58.79
A
25881
D
Common Stock
2023-06-14
4
S
0
100
194.73
D
25781
D
Common Stock
2023-06-14
4
S
0
2104
193.296
D
23677
D
Common Stock
60000
I
by Trust
Non-Qualified Stock Option (right to buy)
58.79
2023-06-14
4
M
0
6712
0.0
D
2018-02-13
2024-02-24
Common Stock
6712
199654
D
Non-Qualified Stock Option (right to buy)
58.79
2023-06-14
4
M
0
3637
0.0
D
2018-02-13
2024-02-24
Common Stock
3637
196017
D
Non-Qualified Stock Option (right to buy)
58.79
2023-06-14
4
M
0
2781
0.0
D
2018-02-13
2024-02-24
Common Stock
2781
193236
D
Non-Qualified Stock Option (right to buy)
58.79
2023-06-14
4
M
0
8163
0.0
D
2018-02-13
2024-02-24
Common Stock
8163
185073
D
Non-Qualified Stock Option (right to buy)
58.79
2023-06-14
4
M
0
785
0.0
D
2018-02-13
2024-02-24
Common Stock
785
184288
D
Non-Qualified Stock Option (right to buy)
58.79
2023-06-14
4
M
0
1699
0.0
D
2018-02-13
2024-02-24
Common Stock
1699
182589
D
Non-Qualified Stock Option (right to buy)
58.79
2023-06-14
4
M
0
1601
0.0
D
2018-02-13
2024-02-24
Common Stock
1601
180988
D
Non-Qualified Stock Option (right to buy)
58.79
2023-06-14
4
M
0
2104
0.0
D
2018-02-13
2024-02-24
Common Stock
2104
178884
D
Non-Qualified Stock Option (right to buy)
58.79
2023-06-14
4
M
0
2418
0.0
D
2018-02-13
2024-02-24
Common Stock
2418
176466
D
Non-Qualified Stock Option (right to buy)
58.79
2023-06-14
4
M
0
100
0.0
D
2018-02-13
2024-02-24
Common Stock
100
176366
D
The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.04 to $186.03, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.05 to $187.04, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $187.05 to $188.03, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.06 to $189.03, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.06 to $189.89, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.16 to $191.12, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.44 to $192.385, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.58 to $194.21, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
All shares sold were sold at the exact price disclosed.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.52 to $193.515, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
This transaction represented a gift of securities from the reporting person to two trusts for the benefit of family members, who share the same household. The reporting person disclaims beneficial ownership of the shares held by the trusts, and this report shall not be deemed as an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose.
Vivek Jain
2023-06-15